Asuku Malachy, Yu Tzy-Chyi, Yan Qi, Böing Elaine, Hahn Helen, Hovland Sara, Donelan Matthias B
Mallinckrodt Pharmaceuticals, Shelbourne Building, 53 Frontage Rd Suite 300, Hampton, NJ, 08827, USA.
Mallinckrodt Pharmaceuticals, Shelbourne Building, 53 Frontage Rd Suite 300, Hampton, NJ, 08827, USA.
Burns. 2021 Nov;47(7):1525-1546. doi: 10.1016/j.burns.2021.02.014. Epub 2021 Feb 25.
The purpose of this systematic literature review is to critically evaluate split-thickness skin graft (STSG) donor-site morbidities. The search of peer-reviewed articles in three databases from January 2009 to July 2019 identified 4271 English-language publications reporting STSG donor-site clinical outcomes, complications, or quality of life. Of these studies, 77 met inclusion criteria for analysis. Mean time to donor-site epithelialization ranged from 4.7 to 35.0 days. Mean pain scores (0-10 scale) ranged from 1.24 to 6.38 on postoperative Day 3. Mean scar scores (0-13 scale) ranged from 0 to 10.9 at Year 1. One study reported 28% of patients had donor-site scar hypertrophy at 8 years. Infection rates were generally low but ranged from 0 to 56%. Less frequently reported outcomes included pruritus, wound exudation, and esthetic dissatisfaction. Donor-site wounds underwent days of wound care and were frequently associated with pain and scarring. Widespread variations were noted in STSG donor-site outcomes likely due to inconsistencies in the definition of outcomes and utilization of various assessment tools. Understanding the true burden of donor sites may drive innovative treatments that would reduce the use of STSGs and address the associated morbidities.
本系统文献综述的目的是严格评估中厚皮片(STSG)供皮区的发病率。在2009年1月至2019年7月期间,对三个数据库中的同行评审文章进行检索,共识别出4271篇报告STSG供皮区临床结果、并发症或生活质量的英文出版物。其中,77项研究符合纳入分析的标准。供皮区上皮化的平均时间为4.7至35.0天。术后第3天的平均疼痛评分(0-10分制)为1.24至6.38分。1年后的平均瘢痕评分(0-13分制)为0至10.9分。一项研究报告称,8年后28%的患者出现供皮区瘢痕增生。感染率一般较低,但范围为0至56%。较少报道的结果包括瘙痒、伤口渗出和美观不满意。供皮区伤口需要进行数天的伤口护理,且常伴有疼痛和瘢痕形成。STSG供皮区的结果存在广泛差异,这可能是由于结果定义和各种评估工具使用的不一致所致。了解供皮区的真正负担可能会推动创新治疗方法的发展,从而减少STSG的使用并解决相关的发病率问题。